[Chloroquine- and fansidar-resistant falciparum malaria treated with minocycline].
D000328:Adult; D002738:Chloroquine / Q000494:pharmacology*; D004338:Drug Combinations / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D008911:Minocycline / Q000627:therapeutic use*; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000494:pharmacology*; D013413:Sulfadoxine / Q000494:pharmacology*; D013424:Sulfanilamides / Q000494:pharmacology*; D013754:Tetracyclines / Q000627:therapeutic use*
D004338:Drug Combinations; D013424:Sulfanilamides; D013754:Tetracyclines; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D008911:Minocycline; D011739:Pyrimethamine
Malária falciparum resistente à cloroquina e ao fansidar tratada com minociclina.